PriceTargets.com logo

Joint - JYNT Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $17.00
  • Forecasted Upside: 93.40%
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.79 As of 05/4/2026 05:00 PM ET
▼ -0.11 (-1.24%)

This chart shows the closing price for JYNT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Joint Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for JYNT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for JYNT

Analyst Price Target is $17.00
▲ +93.40% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Joint in the last 3 months. The average price target is $17.00, with a high forecast of $18.00 and a low forecast of $16.00. The average price target represents a 93.40% upside from the last price of $8.79.

This chart shows the closing price for JYNT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 polled investment analysts is to hold stock in Joint. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/8/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/4/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
5/4/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/13/2026Zacks ResearchDowngradeStrong-Buy ➝ Hold
3/13/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
1/22/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/7/2025B. Riley FinancialDowngradeBuy ➝ Hold
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
8/8/2025B. Riley FinancialLower TargetBuy ➝ Buy$20.00 ➝ $18.00
5/9/2025Lake Street CapitalLower TargetBuy ➝ Buy$20.00 ➝ $16.00
11/8/2024Roth MkmLower TargetBuy ➝ Buy$16.00 ➝ $15.00
5/6/2024B. Riley FinancialBoost TargetBuy ➝ Buy$12.00 ➝ $20.00
5/3/2024Roth MkmReiterated RatingBuy ➝ Buy$13.00 ➝ $16.00
9/19/2023Craig HallumInitiated CoverageHold
9/18/2023Lake Street CapitalLower Target$50.00 ➝ $30.00
9/14/2023Roth MkmLower TargetBuy ➝ Buy$16.00 ➝ $13.00
8/11/2023Roth MkmLower TargetBuy ➝ Buy$21.00 ➝ $16.00
8/11/2023Maxim GroupDowngradeBuy ➝ Hold
3/13/2023DA DavidsonUpgradeUnderperform ➝ Neutral$12.00 ➝ $15.00
3/10/2023B. Riley FinancialBoost Target$23.00 ➝ $26.00
8/8/2022DA DavidsonLower TargetUnderperform$13.00 ➝ $12.00
8/5/2022Maxim GroupUpgradeHold ➝ Buy$36.00
8/5/2022B. Riley FinancialUpgradeNeutral ➝ Buy$31.00
5/9/2022Roth MkmLower Target$75.00 ➝ $40.00
5/9/2022DA DavidsonDowngradeNeutral ➝ Underperform$69.00 ➝ $13.00
5/6/2022Lake Street CapitalLower Target$100.00 ➝ $50.00
5/6/2022B. Riley FinancialDowngradeBuy ➝ Neutral
5/6/2022Craig HallumDowngradeBuy ➝ Hold$90.00 ➝ $30.00
2/25/2022B. Riley FinancialLower Target$125.00 ➝ $88.00
2/25/2022Lake Street CapitalLower Target$150.00 ➝ $100.00
2/25/2022DA DavidsonLower TargetBuy$128.00 ➝ $69.00
1/24/2022Craig HallumLower Target$117.00 ➝ $90.00
11/8/2021Roth MkmBoost TargetBuy$105.00 ➝ $110.00
11/5/2021Maxim GroupReiterated RatingHold
8/9/2021DA DavidsonBoost TargetBuy$65.00 ➝ $128.00
8/6/2021Roth MkmBoost TargetBuy$100.00 ➝ $105.00
8/6/2021Lake Street CapitalBoost TargetBuy$70.00 ➝ $150.00
8/3/2021B. Riley FinancialBoost TargetBuy$65.00 ➝ $105.00
7/29/2021Craig HallumBoost TargetBuy$61.00 ➝ $100.00
6/28/2021Roth MkmBoost TargetBuy$65.00 ➝ $100.00
6/3/2021Maxim GroupDowngradeBuy ➝ Hold
5/10/2021DA DavidsonBoost TargetBuy$57.00 ➝ $65.00
(Data available from 5/4/2021 forward)

News Sentiment Rating

0.19 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 5 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 5 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/4/2026
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/3/2026
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2026
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2026
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2026

Current Sentiment

  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Joint logo
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $8.79
Low: $8.57
High: $9.03

50 Day Range

MA: $8.74
Low: $8.17
High: $9.36

52 Week Range

Now: $8.79
Low: $7.50
High: $13.47

Volume

26,970 shs

Average Volume

34,369 shs

Market Capitalization

$125.87 million

P/E Ratio

46.27

Dividend Yield

N/A

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Joint?

The following sell-side analysts have issued reports on Joint in the last twelve months: B. Riley Financial, Inc., Lake Street Capital, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for JYNT.

What is the current price target for Joint?

0 Wall Street analysts have set twelve-month price targets for Joint in the last year. Their average twelve-month price target is $17.00, suggesting a possible upside of 93.4%. B. Riley Financial, Inc. has the highest price target set, predicting JYNT will reach $18.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $16.00 for Joint in the next year.
View the latest price targets for JYNT.

What is the current consensus analyst rating for Joint?

Joint currently has 1 sell rating, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in JYNT, but not buy more shares or sell existing shares.
View the latest ratings for JYNT.

What other companies compete with Joint?

Other companies that are similar to Joint include Farmland Partners, GAMCO Investors, Community Healthcare Trust, Industrial Logistics Properties Trust and Global Medical REIT. Learn More about companies similar to Joint.

How do I contact Joint's investor relations team?

Joint's physical mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company's listed phone number is (480) 245-5960 and its investor relations email address is [email protected]. The official website for Joint is www.thejoint.com. Learn More about contacing Joint investor relations.